{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:09:13Z","timestamp":1759410553384},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2015]]},"abstract":"<jats:p>OBJECTIVE To analyze the costs of vaccination regimens for introducing inactivated polio vaccine in routine immunization in Brazil.METHODS A cost analysis was conducted for vaccines in five vaccination regimens, including inactivated polio vaccine, compared with the oral polio vaccine-only regimen. The costs of the vaccines were estimated for routine use and for the \u201cNational Immunization Days\u201d, during when the oral polio vaccine is administered to children aged less than five years, independent of their vaccine status, and the strategic stock of inactivated polio vaccine. The presented estimated costs are of 2011.RESULTS The annual costs of the oral vaccine-only program (routine and two National Immunization Days) were estimated at US$19,873,170. The incremental costs of inclusion of the inactivated vaccine depended on the number of vaccine doses, presentation of the vaccine (bottles with single dose or ten doses), and number of \u201cNational Immunization Days\u201d carried out. The cost of the regimen adopted with two doses of inactivated vaccine followed by three doses of oral vaccine and one \u201cNational Immunization Day\u201d was estimated at US$29,653,539. The concomitant replacement of the DTPw\/Hib and HepB vaccines with the pentavalent vaccine enabled the introduction of the inactivated polio without increasing the number of injections or number of visits needed to complete the vaccination.CONCLUSIONS The introduction of the inactivated vaccine increased the annual costs of the polio vaccines by 49.2% compared with the oral vaccine-only regimen. This increase represented 1.13% of the expenditure of the National Immunization Program on the purchase of vaccines in 2011.<\/jats:p>","DOI":"10.1590\/s0034-8910.2015049005492","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T15:58:57Z","timestamp":1424879937000},"source":"Crossref","is-referenced-by-count":6,"title":["Polio inactivated vaccine costs into routine childhood immunization in Brazil"],"prefix":"10.1590","volume":"49","author":[{"given":"Ana Marli Christovam","family":"Sartori","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Universidade de S\u00e3o Paulo,  Brasil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete Paganotti","family":"Vicentine","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edgia Castelloni Figueiredo","family":"Gryninger","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Coelho de","family":"So\u00e1rez","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillegonda Maria Dutilh","family":"Novaes","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander LN","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1590\/S1020-49892010000500005","article-title":"Economic impact of introducing the injectable inactivated polio vaccine in Colombia","volume":"27","author":"Alvis N","year":"2010","journal-title":"Rev Panam Salud Publica"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"Asturias EJ","year":"2007","journal-title":"J Infect Dis"},{"issue":"9916","key":"ref4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(14)60132-X","article-title":"Polio in Syria","volume":"383","author":"Aylward RB","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jech-2011-200341","article-title":"Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008","volume":"66","author":"Barata RB","year":"2012","journal-title":"J Epidemiol Community Health"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.02954-12","article-title":"Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria","volume":"87","author":"Burns CC","year":"2013","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1590\/S0104-59702003000500007","article-title":"A hist\u00f3ria da poliomielite no Brasil e seu controle por imuniza\u00e7\u00e3o","volume":"10","author":"Campos ALV","year":"2003","journal-title":"Hist Cienc Saude Manguinhos"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan GH","year":"2007","journal-title":"J Infect Dis"},{"issue":"29-30","key":"ref9","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2006.05.032","article-title":"The cost-effectiveness of alternative polio immunization policies in South Africa","volume":"24","author":"Griffiths UK","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/infdis\/jit602","article-title":"Vaccine-associated paralytic poliomyelitis in the postelimination era in Latin America and the Caribbean, 1992-2011","volume":"209","author":"Landaverde JM","year":"2014","journal-title":"J Infect Dis"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4161\/hv.25407","article-title":"Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries","volume":"9","author":"Mahmood K","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1996.03540120045032","article-title":"Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule","volume":"276","author":"Miller MA","year":"1996","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.1016\/j.vaccine.2011.04.127","article-title":"Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer","volume":"9","author":"Miyaki C","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/S1413-81232011000200013","article-title":"As campanhas de vacina\u00e7\u00e3o contra a poliomielite no Brasil (1960-1990)","volume":"16","author":"Nascimento DR","year":"2011","journal-title":"Cienc Saude Coletiva"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/erv.12.28","article-title":"Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis","volume":"11","author":"Pliaka V","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"8591","key":"ref16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(88)91711-4","article-title":"Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine","volume":"331","author":"Robertson SE","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1586\/erv.10.39","article-title":"Switching from OPV to IPV: are we behind the schedule in Latin America?","volume":"9","author":"Salas-Peraza D","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.1016\/j.vaccine.2012.02.056","article-title":"Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa","volume":"30","author":"Schoub BD","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"ref19","first-page":"21","article-title":"The occurrence of vaccine-associated paralytic poliomyelitis in Brazil, 1995 to 2001","volume":"18","author":"Teixeira-Rocha ES","year":"2005","journal-title":"Rev Panam Salud Publica"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1467-842X.2001.tb00648.x","article-title":"Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia","volume":"25","author":"Tucker AW","year":"2001","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.10.45","article-title":"Challenges faced by the global polio eradication initiative","volume":"9","author":"Wassilak S","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"33","key":"ref22","first-page":"349","article-title":"Poliomyelitis outbreak in Somalia and Kenya, 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"9","key":"ref23","first-page":"73","article-title":"Polio vaccines: WHO position paper, January 2014","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"21","key":"ref24","first-page":"221","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2014: conclusions and recommendations","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Revista de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsp\/v49\/0034-8910-rsp-S0034-89102015049005492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T23:02:50Z","timestamp":1495494170000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89102015000100211&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2015]]}},"alternative-id":["S0034-89102015000100211"],"URL":"https:\/\/doi.org\/10.1590\/s0034-8910.2015049005492","relation":{},"ISSN":["0034-8910"],"issn-type":[{"value":"0034-8910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}